The federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of Tenvos Inc.'s artificial intelligence-based technology to remotely detect opioid use from 15 seconds of speech. The $586,340 grant, awarded on September 15, 2024, aims to further develop this non-invasive screening solution and understand the effects of opioids on vocal characteristics. The project involves a multi-site observational study at Doctors Medical Center and Loma Linda University Health to collect voice samples before and after opioid administration, which will provide data to train the machine learning model and assess its accuracy. Loma Linda University is serving as a sub-grantee, responsible for the initial data collection from emergency room patients. This project seeks to address barriers to substance use disorder diagnosis and treatment by enabling remote, instant screening, which can improve clinical workflows, reduce costs, and enhance patient care quality, particularly for underserved populations.
Generated 3/4/25, 6:49 AM